H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo
Author:
Funder
National Natural Science Foundation of China
Key Research Project of Shandong Province
State Key Laboratory of Drug Research
Yantai University
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference42 articles.
1. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review;Abdallah;J. Adv. Res.,2015
2. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer;Amiri-Kordestani;Chemotherapy,2012
3. In vitro activity of hederacolchisid A1 compared with other saponins from Hedera colchica against proliferation of human carcinoma and melanoma cells;Barthomeuf;Planta Med.,2002
4. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?;Callaghan;Drug Metab. Dispos.,2014
5. Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies;Chufan;Adv. Cancer Res.,2015
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bisdemethoxycurcumin Augments Docetaxel Efficacy for Treatment of Prostate Cancer;Biological and Pharmaceutical Bulletin;2024-08-15
2. An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives;Frontiers in Pharmacology;2024-06-19
3. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance;European Journal of Medicinal Chemistry;2024-06
4. Graphene Quantum Dots Eradicate Resistant and Metastatic Cancer Cells by Enhanced Interfacial Inhibition;Advanced Healthcare Materials;2024-04-17
5. A Novel 3-meta-Pyridine-1,2,4-oxadiazole Derivative of Glycyrrhetinic Acid as a Safe and Promising Candidate for Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells;ACS Omega;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3